Lack of response to anti-PDL1 therapy has been associated with a TGFβ signature in fibroblasts in urothelial cancer, and concurrent TGFβ blockade facilitated T-cell penetration, provoking anti-tumour immunity and tumour regression [81,132]. Here, CD274 is linked to neoplasm.